Therapeutic Solutions International Announces Launching of Phase III Clinical Trial for Treating COVID-19 Lung Damage Using Its JadiCell™ Universal Donor Stem Cell Drug

Therapeutic Solutions International, Inc. announced filing of an IND and FDA seeking permission to treat 10 patients with advanced COPD using its universal donor adult stem cell product termed “JadiCell™”.
[Therapeutic Solutions International, Inc.]
Press Release
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News